Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 649290, 6 pages
http://dx.doi.org/10.1155/2012/649290
Review Article

PBC: Animal Models of Cholangiopathies and Possible Endogenous Viral Infections

Division of Gastroenterology, Department of Gastroenterology, Tohoku University Graduate School of Medicine, Seiryo, Aoba-ku, Sendai 980-8575, Japan

Received 2 April 2011; Accepted 19 June 2011

Academic Editor: A. J. Demetris

Copyright © 2012 Masashi Ninomiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Nakanuma and G. Ohta, “Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis,” Gastroenterology, vol. 76, no. 6, pp. 1326–1332, 1979. View at Google Scholar · View at Scopus
  2. M. E. Gershwin, I. R. Mackay, A. Sturgess, and R. L. Coppel, “Identification and specificity of a cDNA encoding the 70 KD mitochondrial antigen recognized in primary biliary cirrhosis,” Journal of Immunology, vol. 138, no. 10, pp. 3525–3531, 1987. View at Google Scholar · View at Scopus
  3. R. L. Coppel, L. J. McNeilage, C. D. Surh et al., “Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 19, pp. 7317–7321, 1988. View at Google Scholar · View at Scopus
  4. J. van de Water, A. A. Ansari, C. D. Surh et al., “Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis,” Journal of Immunology, vol. 146, no. 1, pp. 89–94, 1991. View at Google Scholar · View at Scopus
  5. D. E. J. Jones, J. M. Palmer, O. F. W. James, S. J. Yeaman, M. F. Bassendine, and A. G. Diamond, “T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis,” Hepatology, vol. 21, no. 4, pp. 995–1002, 1995. View at Google Scholar · View at Scopus
  6. K. Harada, S. Ozaki, M. E. Gershwin, and Y. Nakanuma, “Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis,” Hepatology, vol. 26, no. 6, pp. 1399–1405, 1997. View at Google Scholar · View at Scopus
  7. J. A. Odin, R. C. Huebert, L. Casciola-Rosen, N. F. LaRusso, and A. Rosen, “Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis,” Journal of Clinical Investigation, vol. 108, no. 2, pp. 223–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tanaka, P. S. C. Leung, T. P. Kenny et al., “Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis,” Journal of Autoimmunity, vol. 17, no. 1, pp. 89–98, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. P. M. Fussey, S. T. Ali, J. R. Guest, O. F. W. James, M. F. Bassendine, and S. J. Yeaman, “Reactivity of primary biliary cirrhosis sera Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 10, pp. 3987–3991, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Long, C. Quan, J. van de Water et al., “Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis,” Journal of Immunology, vol. 167, no. 5, pp. 2956–2963, 2001. View at Google Scholar · View at Scopus
  11. P. S. C. Leung, C. Quan, O. Park et al., “Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies,” Journal of Immunology, vol. 170, no. 10, pp. 5326–5332, 2003. View at Google Scholar · View at Scopus
  12. L. Xu, Z. Shen, L. Guo et al., “Does a betaretrovirus infection trigger primary biliary cirrhosis?” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8454–8459, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. Schembri and P. Schober, “Killing two birds with one stone,” The Lancet, vol. 377, no. 9759, p. 96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. N. R. Rose, “Mechanisms of autoimmunity,” Seminars in Liver Disease, vol. 22, no. 4, pp. 387–394, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Shimoda, M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho, “HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1835–1845, 1995. View at Google Scholar · View at Scopus
  16. J. van de Water, H. Ishibashi, R. L. Coppel, and M. E. Gershwin, “Molecular mimicry and primary biliary cirrhosis: premises not promises,” Hepatology, vol. 33, no. 4, pp. 771–775, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Regner and P. H. Lambert, “Autoimmunity through infection or immunization?” Nature immunology, vol. 2, no. 3, pp. 185–188, 2001. View at Google Scholar · View at Scopus
  18. G. Zhang, M. Chen, D. Graham et al., “Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models,” Journal of Hepatology. In press.
  19. S. Oertelt, Z. X. Lian, C. M. Cheng et al., “Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice,” Journal of Immunology, vol. 177, no. 3, pp. 1655–1660, 2006. View at Google Scholar · View at Scopus
  20. C. A. Aoki, C. M. Roifman, Z. X. Lian et al., “IL-2 receptor alpha deficiency and features of primary biliary cirrhosis,” Journal of Autoimmunity, vol. 27, no. 1, pp. 50–53, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Koarada, Y. Wu, N. Fertig et al., “Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain,” Journal of Immunology, vol. 173, no. 4, pp. 2315–2323, 2004. View at Google Scholar · View at Scopus
  22. J. Massague, “TGF-beta signal transduction,” Annual Review of Biochemistry, vol. 67, pp. 753–791, 1998. View at Google Scholar
  23. L. Gorelik and R. A. Flavell, “Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease,” Immunity, vol. 12, no. 2, pp. 171–181, 2000. View at Google Scholar · View at Scopus
  24. K. Harada, K. Isse, K. Tsuneyama, H. Ohta, and Y. Nakanuma, “Accumulating CD57+CD3+ natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis,” Liver International, vol. 23, no. 2, pp. 94–100, 2003. View at Google Scholar · View at Scopus
  25. S. Oertelt, W. M. Ridgway, A. A. Ansari, R. L. Coppel, and M. E. Gershwin, “Murine models of primary biliary cirrhosis: comparisons and contrasts,” Hepatology Research, vol. 37, no. 3, pp. S365–S369, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Shindo, G. E. Mullin, L. Braun-Elwert, N. V. Bergasa, E. A. Jones, and S. P. James, “Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB),” Clinical and Experimental Immunology, vol. 105, no. 2, pp. 254–259, 1996. View at Google Scholar · View at Scopus
  27. M. Yasoshima, N. Kono, H. Sugawara, K. Katayanagi, K. Harada, and Y. Nakanuma, “Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: in situ and culture study,” Laboratory Investigation, vol. 78, no. 1, pp. 89–100, 1998. View at Google Scholar · View at Scopus
  28. K. Wakabayashi, Z. X. Lian, Y. Moritoki et al., “IL-2 receptor α/ mice and the development of primary biliary cirrhosis,” Hepatology, vol. 44, no. 5, pp. 1240–1249, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. P. A. Berg, R. Klein, and M. Röcken, “Cytokines in primary biliary cirrhosis,” Seminars in Liver Disease, vol. 17, no. 2, pp. 115–123, 1997. View at Google Scholar · View at Scopus
  30. J. Irie, Y. Wu, L. S. Wicker et al., “NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis,” Journal of Experimental Medicine, vol. 203, no. 5, pp. 1209–1219, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P. Humbert and J. L. Dupond, “Multiple autoimmune syndromes (MAS),” Annales de Medecine Interne, vol. 139, no. 3, pp. 159–168, 1988. View at Google Scholar · View at Scopus
  32. K. O. Gtc, C. C. Szeto, V. Yeung, C. C. Chow, H. Chan, and C. S. Cockram, “Autoimmune polyglandular syndrome and primary biliary cirrhosis,” British Journal of Clinical Practice, vol. 50, no. 6, pp. 344–346, 1996. View at Google Scholar · View at Scopus
  33. J. P. Lin, J. M. Cash, S. Z. Doyle et al., “Familial clustering of rheumatoid arthritis with other autoimmune diseases,” Human Genetics, vol. 103, no. 4, pp. 475–482, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. M. Griffiths, J. A. Encinas, E. F. Remmers, V. K. Kuchroo, and R. L. Wilder, “Mapping autoimmunity genes,” Current Opinion in Immunology, vol. 11, no. 6, pp. 689–700, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Ueno, Y. Moritoki, T. Shimosegawa, and M. E. Gershwin, “Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models,” Journal of Gastroenterology, vol. 42, no. 3, pp. 189–195, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. Y. Nakagome, Y. Ueno, T. Kogure et al., “Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency,” Journal of Autoimmunity, vol. 29, no. 1, pp. 20–29, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. S. Munoz, S. Ballas, R. Norberg, and W. Maddrey, “Antibodies to human immunodeficiency virus (HIV) in primary biliary cirrhosis,” Gastroenterology, vol. 94, p. A574, 1988. View at Google Scholar
  38. N. Talal, M. J. Dauphinee, H. Dang, S. S. Alexander, D. J. Hart, and R. F. Garry, “Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy),” Arthritis and Rheumatism, vol. 33, no. 6, pp. 774–781, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Talal, R. F. Garry, P. H. Schur et al., “A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 85, no. 6, pp. 1866–1871, 1990. View at Google Scholar · View at Scopus
  40. A. L. Mason, L. Xu, L. Guo et al., “Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders,” The Lancet, vol. 351, no. 9116, pp. 1620–1624, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Xu, M. Sakalian, Z. Shen, G. Loss, J. Neuberger, and A. Mason, “Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis,” Hepatology, vol. 39, no. 1, pp. 151–156, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. C. Selmi, S. R. Ross, A. A. Ansari et al., “Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis,” Gastroenterology, vol. 127, no. 2, pp. 493–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Mason, G. H. Farr, L. Xu, S. G. Hubscher, and J. M. Neuberger, “Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis,” American Journal of Gastroenterology, vol. 99, no. 12, pp. 2348–2355, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. A. L. Mason, K. D. Lindor, B. R. Bacon, C. Vincent, J. M. Neuberger, and S. T. Wasilenko, “Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 7, pp. 886–894, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. K. Fukushima, Y. Ueno, and T. Shimosegawa, “Treatment of primary biliary cirrhosis: a new challenge?” Hepatology Research, vol. 40, no. 1, pp. 61–68, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. M. Chen, D. Graham, S. Girgis et al., “Combination antiretroviral therapy with Combivir attenuates autoimmune biliary disease in the NOD.c3c4 mouse model of primary biliary cirrhosis,” Hepatology, vol. 46, supplement 1, p. 548A, 2007. View at Google Scholar
  47. D. Graham, M. Chen, S. Girgis, G. Zhang, and A. Mason, “Highly active anti-retroviral therapy completely abrogates cholangitis in the NOD.c3c4 mouse model of PBC,” Journal of Hepatology, vol. 2, p. s54, 2008. View at Google Scholar
  48. G. R. Locke III, T. M. Therneau, J. Ludwig, E. R. Dickson, and K. D. Lindor, “Time course of histological progression in primary biliary cirrhosis,” Hepatology, vol. 23, no. 1, pp. 52–56, 1996. View at Publisher · View at Google Scholar
  49. S. Nagata and P. Golstein, “The Fas death factor,” Science, vol. 267, no. 5203, pp. 1449–1456, 1995. View at Google Scholar
  50. T. Sakai, Y. Kimura, K. Inagaki-Ohara, K. Kusugami, D. H. Lynch, and Y. Yoshikai, “Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice,” Gastroenterology, vol. 113, no. 1, pp. 168–174, 1997. View at Publisher · View at Google Scholar
  51. Y. Ueno, M. Ishii, K. Yahagi et al., “Fas-mediated cholangiopathy in the murine model of graft versus host disease,” Hepatology, vol. 31, no. 4, pp. 966–974, 2000. View at Google Scholar
  52. N. Hiramatsu, N. Hayashi, K. Katayama et al., “Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C,” Hepatology, vol. 19, no. 6, pp. 1354–1359, 1994. View at Publisher · View at Google Scholar
  53. M. Iwata, K. Harada, K. Hiramatsu et al., “Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis,” Liver, vol. 20, no. 2, pp. 129–135, 2000. View at Publisher · View at Google Scholar
  54. F. G. Que, V. A. Phan, V. H. Phan et al., “Cholangiocarcinomas express Fas ligand and disable the Fas receptor,” Hepatology, vol. 30, no. 6, pp. 1398–1404, 1999. View at Google Scholar
  55. M. Chen, D. Graham, G. Zhang et al., “Biliary infection with mouse mammary tumor virus in the NOD.c3c4 mouse and other mouse models of primary biliary cirrhosis,” Hepatology, vol. 46, supplement 1, p. 551A, 2007. View at Google Scholar